Notícias e Atividades da Inovio Pharmaceuticals

Inovio Pharmaceuticals é uma empresa listada sob o símbolo INO (US).

Veja o organograma con seus 22 executivos principais

Biografias mais buscadas da Inovio Pharmaceuticals

• Jacqueline Shea, President and Chief Executive Officer
• Wendy Yarno, Director
• Ann Miller, Director

Criar um alerta
para seguir os movimentos de executivos da Inovio Pharmaceuticals.

Inovio Pharmaceuticals possui 2.351 concorrentes concorrentes Astellas Gene Therapies (Estados Unidos), Eurofins (Luxemburgo) e Lonza (Suíça).

Popular M&A news in Biotecnologia

• Draig Therapeutics acaba de anunciar uma arrecadação de fundos de 140 milhões de dólares. (publicado em 18 de junho de 2025).
• Eli Lilly has announced the acquisition of Verve Therapeutics  (publicado em 17 de junho de 2025).
• Sirius Therapeutics acaba de anunciar uma arrecadação de fundos de 50 milhões de dólares. (publicado em 16 de junho de 2025).

Outros contatos sugeridos na indústria do Biotecnologia

• Sandra Smith - Senior Vice President, Clinical Solutions & Strategic Partnerships da WIRB-Copernicus Group
• Jasbir Seehra - Chief Executive Officer and Chairman of the Board da Keros Therapeutics
• Deepika Verma - Associate Director of Data Science and Digitalization da Wheeler Bio

Saiba mais sobre a indústria do Biotecnologia

Últimos comunicados de imprensa de Inovio Pharmaceuticals

• INOVIO Announces Pricing of $30 Million Public Offering
• INOVIO Announces Proposed Public Offering
• INOVIO Reports Inducement Grant Under Inducement Plan
• New Retrospective Data Shows Half of RRP Patients Treated with INO-3107 Achieved a Complete Response When Evaluated 2 and 3 Years Following Initial Phase 1/2 Trial
• INOVIO Reports Third Quarter 2024 Financial Results and Recent Business Highlights
• Immunology Data Shows INOVIO's INO-3107 Induced Expansion of New Clonal T Cells That Infiltrate Airway Tissue and Correspond With Reduction of Surgeries for RRP Patients Observed in Phase 1/2 Trial
• INOVIO to Report Third Quarter 2024 Financial Results on November 14, 2024
• INOVIO to Present at Upcoming Scientific Conferences
• INOVIO Announces New Data at Scientific Conferences for Lead Candidate, INO-3107, as a Potential Treatment for RRP
• INOVIO to Present at Upcoming Scientific Conferences
• View more press releases Close

Redes sociais sobre Inovio Pharmaceuticals

• Inovio Pharmaceuticals na Wikipedia, Google News e Yahoo Finance
• Inovio Pharmaceuticals na LinkedIn, Twitter e YouTube